These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 23982943)

  • 1. Development and application of FRAX in the management of osteoporosis in Ireland.
    McGowan B; Kanis JA; Johansson H; Silke C; Whelan B
    Arch Osteoporos; 2013; 8():146. PubMed ID: 23982943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FRAX-based intervention and assessment thresholds for osteoporosis in Romania.
    Grigorie D; Sucaliuc A; Johansson H; Kanis JA; McCloskey E
    Arch Osteoporos; 2013; 8():164. PubMed ID: 24390553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
    Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of hip fracture in Romania and the development of a Romanian FRAX model.
    Grigorie D; Sucaliuc A; Johansson H; Kanis JA; McCloskey E
    Calcif Tissue Int; 2013 May; 92(5):429-36. PubMed ID: 23334302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of hip fracture in Barranquilla, Colombia, and the development of a Colombian FRAX model.
    Jaller-Raad JJ; Jaller-Char JJ; Lechuga-Ortiz JA; Navarro-Lechuga E; Johansson H; Kanis JA
    Calcif Tissue Int; 2013 Jul; 93(1):15-22. PubMed ID: 23471427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
    Khashayar P; Keshtkar A; Ostovar A; Larijani B; Johansson H; Harvey NC; Lorentzon M; McCloskey E; Kanis JA
    Osteoporos Int; 2019 Nov; 30(11):2225-2230. PubMed ID: 31372709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hip fracture in Brazil and the development of a FRAX model.
    Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
    Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FRAX- vs. T-score-based intervention thresholds for osteoporosis.
    Johansson H; Azizieh F; Al Ali N; Alessa T; Harvey NC; McCloskey E; Kanis JA
    Osteoporos Int; 2017 Nov; 28(11):3099-3105. PubMed ID: 28782072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures.
    Lalmohamed A; Welsing PM; Lems WF; Jacobs JW; Kanis JA; Johansson H; De Boer A; De Vries F
    Osteoporos Int; 2012 Mar; 23(3):861-9. PubMed ID: 22120910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of changes in mortality on FRAX-derived fracture probabilities.
    Kreidieh OI; El-Hajj Fuleihan G
    Bone; 2014 May; 62():43-50. PubMed ID: 24480305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
    Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model.
    Lopez Gavilanez E; Johansson H; McCloskey E; Harvey NC; Segale Bajana A; Marriott Blum D; Navarro Grijalva M; Diaz Curiel M; Kanis JA
    Arch Osteoporos; 2019 Aug; 14(1):93. PubMed ID: 31440846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sri Lankan FRAX model and country-specific intervention thresholds.
    Lekamwasam S
    Arch Osteoporos; 2013; 8():148. PubMed ID: 23975235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FRAX-based fracture probabilities in South Africa.
    Johansson H; Dela SS; Cassim B; Paruk F; Brown SL; Conradie M; Harvey NC; Jordaan JD; Kalla AA; Liu E; Lorentzon M; Lukhele M; McCloskey EV; Mohamed O; Chutterpaul P; Vandenput L; Kanis JA
    Arch Osteoporos; 2021 Mar; 16(1):51. PubMed ID: 33649966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
    Yu R; Leung J; Woo J
    J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FRAX-based intervention thresholds for Pakistan.
    Johansson H; Naureen G; Iqbal R; Jafri L; Khan AH; Umer M; Liu E; Vandenput L; Lorentzon M; McCloskey EV; Kanis JA; Harvey NC
    Osteoporos Int; 2022 Jan; 33(1):105-112. PubMed ID: 34414463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
    Lippuner K
    Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A FRAX model for the estimation of osteoporotic fracture probability in Portugal.
    Marques A; Mota A; Canhão H; Romeu JC; Machado P; Ruano A; Barbosa AP; Dias AA; Silva D; Araújo D; Simões E; Aguas F; Rosendo I; Silva I; Crespo J; Alves JD; Costa L; Mascarenhas M; Lourenço Ó; Ferreira PL; Lucas R; Roque R; Branco JC; Tavares V; Johansson H; Kanis J; Pereira da Silva JA
    Acta Reumatol Port; 2013; 38(2):104-12. PubMed ID: 24141347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort?
    Sornay-Rendu E; Munoz F; Delmas PD; Chapurlat RD
    J Bone Miner Res; 2010 Oct; 25(10):2101-7. PubMed ID: 20499352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FRAX® probabilities and risk of major osteoporotic fracture in France.
    Couris CM; Chapurlat RD; Kanis JA; Johansson H; Burlet N; Delmas PD; Schott AM
    Osteoporos Int; 2012 Sep; 23(9):2321-7. PubMed ID: 22179418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.